Mirae-Asset-Global-Investments-Co

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-04-24
Total Holdings
1,827
Total Value
23729973945
Accession Number
0000905148-25-001297
Form Type
13F-HR
Manager Name
Mirae-Asset-Global-Investments-Co
Data Enrichment
87% identified
1,585 identified242 unidentified

Holdings

1,827 positions • $23.7B total value
Manager:
Search and click to pin securities to the top
Page 74 of 80
Aquestive Therapeutics, Inc.
Shares:3.2K
Value:$9.6K
% of Portfolio:0.0% ($9.6K/$23.7B)
Autolus Therapeutics plc
Shares:5.8K
Value:$9.6K
% of Portfolio:0.0% ($9.6K/$23.7B)
Esperion Therapeutics, Inc.
Shares:6.4K
Value:$9.6K
% of Portfolio:0.0% ($9.6K/$23.7B)
Tectonic Therapeutic, Inc.
Shares:500
Value:$9.3K
% of Portfolio:0.0% ($9.3K/$23.7B)
Alpha Teknova, Inc.
Shares:1.8K
Value:$9.3K
% of Portfolio:0.0% ($9.3K/$23.7B)
Vanda Pharmaceuticals Inc.
Shares:2.0K
Value:$9.2K
% of Portfolio:0.0% ($9.2K/$23.7B)
ZILLOW GROUP, INC.
Shares:135
Value:$9.1K
% of Portfolio:0.0% ($9.1K/$23.7B)
MAXCYTE, INC.
Shares:3.3K
Value:$9.0K
% of Portfolio:0.0% ($9.0K/$23.7B)
ALUMIS INC.
Shares:1.6K
Value:$8.9K
% of Portfolio:0.0% ($8.9K/$23.7B)
CBL & ASSOCIATES PROPERTIES INC
Shares:332
Value:$8.8K
% of Portfolio:0.0% ($8.8K/$23.7B)
ACELYRIN, Inc.
Shares:3.4K
Value:$8.8K
% of Portfolio:0.0% ($8.8K/$23.7B)
OmniAb, Inc.
Shares:3.6K
Value:$8.8K
% of Portfolio:0.0% ($8.8K/$23.7B)
Prime Medicine, Inc.
Shares:4.4K
Value:$8.7K
% of Portfolio:0.0% ($8.7K/$23.7B)
2seventy bio, Inc.
Shares:1.7K
Value:$8.5K
% of Portfolio:0.0% ($8.5K/$23.7B)
Terns Pharmaceuticals, Inc.
Shares:2.8K
Value:$8.3K
% of Portfolio:0.0% ($8.3K/$23.7B)
Atea Pharmaceuticals, Inc.
Shares:2.8K
Value:$8.3K
% of Portfolio:0.0% ($8.3K/$23.7B)
Humacyte, Inc.
Shares:4.1K
Value:$8.1K
% of Portfolio:0.0% ($8.1K/$23.7B)
Annexon, Inc.
Shares:3.6K
Value:$8.0K
% of Portfolio:0.0% ($8.0K/$23.7B)
Design Therapeutics, Inc.
Shares:1.9K
Value:$8.0K
% of Portfolio:0.0% ($8.0K/$23.7B)
Canaan Inc.
Shares:8.7K
Value:$7.9K
% of Portfolio:0.0% ($7.9K/$23.7B)